Innovid Corp. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

BASIC AND DILUTED NET LOSS PER SHARE (Tables)

BASIC AND DILUTED NET LOSS PER SHARE (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of Basic and Diluted Net Loss Per Share

Basic and diluted net loss per share attributable to common stockholders was calculated as follows:


	Year ended December 31,
	2022		2021		2020
Numerator:
Net loss	$	(18,410)	$	(11,472)	$	(812)
Accretion of preferred stocks to redemption value	—		(77,063)		(7,297)
Net loss attributable to common stockholders - basic and diluted	$	(18,410)	$	(88,535)	$	(8,109)
Denominator:
Weighted-average number of stocks used in computing net loss per stock attributable to common stockholders	130,756,484		26,745,020		16,028,560
Net loss per stock attributable to common stockholders – basic and diluted	$	(0.14)	$	(3.31)	$	(0.51)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:


	Year ended December 31,
	2022	2021	2020
Preferred stocks	—	—	73,690,340
Options outstanding	10,755,985	11,302,275	13,204,528
RSUs outstanding	8,116,641	—	—
Warrants outstanding	10,222,500	10,222,500	680,271